Event:

HLA with Oxford Nanopore Technologies

Date: Tuesday 20th October 2020

Time: 3:00 pm (UK time)/ 10:00 am (EST)

Please join us for the next seminar in this series in which you will first hear from James Brayer, Associate Director - Market Development, Oxford Nanopore Technologies Ltd., who will give an overview of the platform before we are joined by Dianne De Santis, Department of Clinical Immunology PathWest, Fiona Stanley Hospital Murdoch, who will present her latest research.

Participants of this webinar will learn about:

  • Long-read sequencing targeting the 11 Class I and II HLA loci in a single test
  • A simple workflow, taking less than 6 hours from sample to report
  • Achieving high resolution (2-field) typing

There will also be an opportunity to submit questions throughout the talks which will be answered in the live Q&A session following the presentations.

Please register below to attend this webinar. You will receive a confirmation of your place from events@nanoporetech.com. 

© 2008 - 2022 Oxford Nanopore Technologies plc. or its subsidiaries. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382 | Privacy & Cookie Policies  |  Terms & Conditions. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.